• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Boule Diagnostics

3.25 SEK

+0.93 %

Less than 1K followers

BOUL

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.93 %
+2.52 %
-17.72 %
-33.81 %
-41.12 %
-59.88 %
-71.39 %
-91.79 %
-64.69 %

Boule Diagnostics operates in the medical technology industry and focuses on the development and manufacture of diagnostic instruments for hematology. The company's products are aimed at healthcare institutions and laboratories. The business is global with a main presence in Europe, North America and Asia. Boule Diagnostics was founded in 1956 and is headquartered in Spånga, Sweden.

Read more
Market cap
126.21M SEK
Turnover
92.17K SEK
Revenue
489.6M
EBIT %
4.55 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17/7
2026

Interim report Q2'26

23/10
2026

Interim report Q3'26

10/2
2027

Annual report '26

Press release5/29/2026, 6:30 AM

Boule Diagnostics utser Simonetta Tumbiolo till Interim VD

Boule Diagnostics
Press release5/29/2026, 6:30 AM

Interim CEO at Boule Diagnostics

Boule Diagnostics
Regulatory press release5/13/2026, 4:00 PM

Kommuniké från Boule Diagnostics årsstämma den 13 maj 2026

Boule Diagnostics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/13/2026, 4:00 PM

Bulletin from the Annual General Meeting May 13, 2026 in Boule Diagnostics

Boule Diagnostics
Regulatory press release4/28/2026, 6:00 AM

Boule Diagnostics delårsrapport Q1 2026

Boule Diagnostics
Regulatory press release4/28/2026, 6:00 AM

Boule Diagnostics Interim Report Q1 2026

Boule Diagnostics
Press release4/27/2026, 3:00 PM

Boule Diagnostics – Inbjudan till presentation av Q1 2026

Boule Diagnostics
Press release4/27/2026, 3:00 PM

Boule Diagnostics – Invitation to presentation of the interim report Q1 2026

Boule Diagnostics
Regulatory press release4/13/2026, 1:00 PM

KALLELSE TILL ÅRSSTÄMMA I BOULE DIAGNOSTICS AB

Boule Diagnostics
Regulatory press release4/10/2026, 3:30 PM

Boule Diagnostics publicerar årsredovisningen för 2025

Boule Diagnostics
Regulatory press release2/11/2026, 7:00 AM

Boule Diagnostics bokslutskommuniké 2025

Boule Diagnostics
Regulatory press release2/11/2026, 7:00 AM

Boule Diagnostics Year-end report 2025

Boule Diagnostics
Press release2/6/2026, 9:30 AM

Boule Diagnostics – Inbjudan till presentation av Q4 2025

Boule Diagnostics
Press release2/6/2026, 9:30 AM

Boule Diagnostics – Invitation to presentation of the Q4 report 2025

Boule Diagnostics
Press release1/21/2026, 7:30 AM

Boule Diagnostics förnyar och utökar ett globalt leveransavtal

Boule Diagnostics
Press release1/21/2026, 7:30 AM

Boule Diagnostics Renews and Expands a Global Supply Agreement

Boule Diagnostics
Regulatory press release12/30/2025, 7:30 AM

Boule Diagnostics utser Michael af Winklerfelt till CFO

Boule Diagnostics
Regulatory press release12/30/2025, 7:30 AM

Boule Diagnostics appoints Michael af Winklerfelt as new CFO

Boule Diagnostics
Press release12/22/2025, 10:00 AM

Boule Diagnostics utvald som en av tre leverantörer i den nationella hematologiupphandlingen i Italien

Boule Diagnostics
Press release12/22/2025, 10:00 AM

Boule Diagnostics Selected as One of Three Providers in Nationwide Hematology Tender in Italy

Boule Diagnostics